NCT03634449

Brief Summary

In the use of the second supraglottic airway device- i-gel in the laparoscopic pneumoperitoneum and Trendelenburg (LPT) surgical positioning, our data reported that the leak fraction in the i-gel group was higher than in the endotracheal tube group.1 These air leak may be gone into the GI tract and cause the gastric distension resulting in the increasing risk of aspiration. Few studies investigated whether the risk of occurrence of the gastroesophageal reflux (GER), the changes of the lower esophageal sphincter (LES) while the GER occurred, and the stomach fullness in the i-gel group than in the endotracheal tube group. We aim to observe the changes of gastroesophageal function parameters by esophageal manometry, pH impedance, and intra-abdominal pressure before and after laparoscopic pneumoperitoneum during anesthesia, all via the second SADs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2018

Completed
4 days until next milestone

Study Start

First participant enrolled

August 13, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 16, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 13, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2020

Completed
Last Updated

January 10, 2019

Status Verified

August 1, 2018

Enrollment Period

1.2 years

First QC Date

August 9, 2018

Last Update Submit

January 8, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • gastroesophageal reflux occurence

    occurence of the gastroesophageal reflux

    during the surgery

Secondary Outcomes (1)

  • lower esophageal sphincter change

    during the surgery

Study Arms (2)

i-gel

EXPERIMENTAL

After anesthetic durg given, i-gel, a supraglottic airway devices with a gastric suction channel, will be inserted into the patients' airway.

Device: i-gel

endotracheal tube

ACTIVE COMPARATOR

After anesthetic durg given, the endotracheal tube, traditional use for protect airway during the laparoscopic surgery, will be inserted into the patients' airway.

Device: endotracheal tube

Interventions

i-gelDEVICE

i-gel is a supraglottic airway devices with a gastric suction channel.

i-gel

Endotracheal intubation is a traditional use for protect airway during the laparoscopic surgery.

endotracheal tube

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who will receive scheduled surgery with laparoscopic pneumoperitoneum and Trendelenburg (LPT) setting under general anesthesia
  • Aged from 20-80 years old

You may not qualify if:

  • Major systemic disease, such as congestive heart failure, liver cirrhosis, end stage renal disease and malignancy.
  • Patients who have the risk of difficult ventilation or intubation.
  • pregnant women
  • coagulopathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chih-Jun Lai

Taipei, Taiwan

RECRUITING

Central Study Contacts

Chih-Jun Lai, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: one group using the endotracheal tube one group using the i-gel
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 9, 2018

First Posted

August 16, 2018

Study Start

August 13, 2018

Primary Completion

October 13, 2019

Study Completion

September 13, 2020

Last Updated

January 10, 2019

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share

due to the privacy of the individual participant data of our patients, we cannot share their data to other researchers. The raw data will be kept very carefully in our research team.

Locations